Birmingham Psychiatry Pharmaceutical Studies, Inc. — Birmingham, Alabama

Birmingham Psychiatry Pharmaceutical Studies, Inc. is a clinical research site located in Birmingham, Alabama, United States 35209.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Birmingham Psychiatry Pharmaceutical Studies, Inc. has participated in 8 clinical trials.

Therapeutic areas: Schizophrenia, Depression, Bipolar I Depression.

Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Bristol-Myers Squibb, Novartis.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Psychiatry Pharmaceutical Studies, Inc.?

Birmingham Psychiatry Pharmaceutical Studies, Inc. has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Psychiatry Pharmaceutical Studies, Inc. conducted?

Birmingham Psychiatry Pharmaceutical Studies, Inc. has 8 clinical trials on record. Their work covers Schizophrenia, Depression, Bipolar I Depression.

Is Birmingham Psychiatry Pharmaceutical Studies, Inc. accredited by Crixeo Health?

Yes — Birmingham Psychiatry Pharmaceutical Studies, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Birmingham Psychiatry Pharmaceutical Studies, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.